Loading...
Refractory necrotizing scleritis successfully treated with adalimumab
Necrotizing scleritis is the most severe and destructive form of scleritis with vision-threatening sequelae. It is divided into with inflammation and without inflammation (scleromalacia perforans). Adalimumab is a tumour necrosis factor (TNF)-inhibiting anti-inflammatory medication licensed for the...
Saved in:
| Published in: | J Ophthalmic Inflamm Infect |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer Berlin Heidelberg
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5059540/ https://ncbi.nlm.nih.gov/pubmed/27734292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12348-016-0107-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|